RxDoctor Payments Data

Masayuki Inouye, MD

Otolaryngology · Hackensack, NJNPI 1861480295

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 30.6% of the total.

$3,715in general payments, 2019–2025

Across 176 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Sanofi$572
  • Optinose US, Inc.$428
  • Regeneron Healthcare Solutions, Inc.$366
  • GSK$231
  • Aerin Medical Inc.$203
  • plus $780 from 15 others

What the payments were for

  • Food & beverage$3,61597%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,715 in reported general payments places this provider in the 85th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$361,345
Medicare patients
836
Services billed
2,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$51,601
Azelastine Hcl143$3,467
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$3,128
Fluticasone Propionate140$2,480
Fluocinonide-EFluocinonide/Emollient Base47$1,460
Mupirocin83$771
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav94$728
Ipratropium Bromide29$586
Montelukast Sodium93$552
Ofloxacin22$544
Levocetirizine Dihydrochloride25$367
Clarithromycin16$312
Omeprazole45$246
Famotidine25$241
Methylprednisolone36$231

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →